Title |
Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk
|
---|---|
Published in |
BMC Public Health, August 2010
|
DOI | 10.1186/1471-2458-10-458 |
Pubmed ID | |
Authors |
Hueiming Liu, Anushka Patel, Alex Brown, Sandra Eades, Noel Hayman, Stephen Jan, Ian Ring, Greg Stewart, Andrew Tonkin, Tarun Weeramanthri, Vicki Wade, Anthony Rodgers, Tim Usherwood, Bruce Neal, David Peiris, Hugh Burke, Christopher Reid, Alan Cass, the Kanyini Vascular Collaboration and Kanyini GAP Study Team |
Abstract |
The Kanyini Guidelines Adherence with the Polypill (Kanyini-GAP) Study aims to examine whether a polypill-based strategy (using a single capsule containing aspirin, a statin and two blood pressure-lowering agents) amongst Indigenous and non-Indigenous people at high risk of experiencing a cardiovascular event will improve adherence to guideline-indicated therapies, and lower blood pressure and cholesterol levels. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Science communicators (journalists, bloggers, editors) | 1 | 50% |
Members of the public | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 75 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 12 | 16% |
Student > Master | 9 | 12% |
Student > Postgraduate | 6 | 8% |
Student > Doctoral Student | 6 | 8% |
Student > Bachelor | 6 | 8% |
Other | 19 | 25% |
Unknown | 17 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 19 | 25% |
Nursing and Health Professions | 8 | 11% |
Social Sciences | 5 | 7% |
Agricultural and Biological Sciences | 4 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 5% |
Other | 13 | 17% |
Unknown | 22 | 29% |